alexa
 
Home News Dr Reddy’s Lab rises over 3% after Srikakulam facility clears USFDA

Read more interesting news from around the globe with Indianmoney App

Google Play
 
Dr Reddy’s Lab rises over 3% after Srikakulam facility clears USFDA

Dr Reddy’s Lab rises over 3% after Srikakulam facility clears USFDA

Monday, April 17, 2017, 12:22 PM

Drug firm Dr. Reddy's Laboratories share on Monday rose 3.1% on an intraday basis as the company said the US health regulator has completed an inspection of its Srikakulam facility without making any observations. The stock on the BSE hit an intraday high of Rs 2721 per share and an intraday low of Rs 2691 per share on the BSE.
Read More

Learn to Save, Spend, Invest & Borrow Wisely with our Youtube Channel

Get It now!